PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28767701-1 2017 OBJECTIVES: Increased expression of adenylyl cyclase type 6 (AC6) has beneficial effects on the heart through cyclic adenosine monophosphate (cAMP)-dependent and cAMP-independent pathways. Cyclic AMP 110-140 adenylate cyclase 6 Mus musculus 36-64 28767701-1 2017 OBJECTIVES: Increased expression of adenylyl cyclase type 6 (AC6) has beneficial effects on the heart through cyclic adenosine monophosphate (cAMP)-dependent and cAMP-independent pathways. Cyclic AMP 142-146 adenylate cyclase 6 Mus musculus 36-64 28767701-1 2017 OBJECTIVES: Increased expression of adenylyl cyclase type 6 (AC6) has beneficial effects on the heart through cyclic adenosine monophosphate (cAMP)-dependent and cAMP-independent pathways. Cyclic AMP 162-166 adenylate cyclase 6 Mus musculus 36-64 28767701-2 2017 We previously generated a catalytically inactive mutant of AC6 (AC6mut) that has an attenuated response to beta-adrenergic receptor stimulation, and, consequently, exhibits reduced myocardial cAMP generation. Cyclic AMP 192-196 adenylate cyclase 6 Mus musculus 59-62 28767701-2 2017 We previously generated a catalytically inactive mutant of AC6 (AC6mut) that has an attenuated response to beta-adrenergic receptor stimulation, and, consequently, exhibits reduced myocardial cAMP generation. Cyclic AMP 192-196 adenylate cyclase 6 Mus musculus 64-70 28767701-5 2017 Isoproterenol infusion caused deleterious effects that were attenuated by cardiac-directed AC6mut expression. Isoproterenol 0-13 adenylate cyclase 6 Mus musculus 91-97 28767701-7 2017 In addition, AC6mut mice showed superior left ventricular function, manifested by higher values for LV peak +dP/dt (p = 0.03), LV peak -dP/dt (p = 0.008), end-systolic pressure-volume relationship (p = 0.003) and cardiac output (p<0.03). dp 109-111 adenylate cyclase 6 Mus musculus 13-19 28767701-7 2017 In addition, AC6mut mice showed superior left ventricular function, manifested by higher values for LV peak +dP/dt (p = 0.03), LV peak -dP/dt (p = 0.008), end-systolic pressure-volume relationship (p = 0.003) and cardiac output (p<0.03). dp 136-138 adenylate cyclase 6 Mus musculus 13-19 28767701-7 2017 In addition, AC6mut mice showed superior left ventricular function, manifested by higher values for LV peak +dP/dt (p = 0.03), LV peak -dP/dt (p = 0.008), end-systolic pressure-volume relationship (p = 0.003) and cardiac output (p<0.03). Thymidine 112-114 adenylate cyclase 6 Mus musculus 13-19 28767701-10 2017 CONCLUSION: Mice with cardiac-directed AC6mut expression weathered the deleterious effects of continuous isoproterenol infusion better than control mice, indicating cardiac protection. Isoproterenol 105-118 adenylate cyclase 6 Mus musculus 39-45